Analysis of treatment-free survival of patients with advanced melanoma receiving nivolumab as monotherapy or in combination with relatlimab in RELATIVITY-047 / Regan, Mm; Ascierto, Pa; Lipson, Ej; Palaia, J; Moshyk, A; Selvan, A; Lao, Cd; Atkins Mb, Md; Mcdermott, Df; Potluri, R; Ranjan, S; Bilthare, S; Long, Gv; Stephen Hodi, F; Tawbi, H; Schadendorf, D. - In: JOURNAL FOR IMMUNOTHERAPY OF CANCER. - ISSN 2051-1426. - (2025). [10.1136/jitc-2025-012747]
Analysis of treatment-free survival of patients with advanced melanoma receiving nivolumab as monotherapy or in combination with relatlimab in RELATIVITY-047
Ascierto PA;
2025
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
